storage i n cystinosis. We studied e f f l u x o f C and leucine, methionine, phenylalanine, tryptophan, and cysteine from i s o l a t e d normal (NL) and c y s t i n o t i c (CY) lysosome-rich leukocyte f r a c t i o n s loaded by incubation w i t h amino acid-methyl esters. The T-1/2 (min) f o r e f f l u x o f the radioactive amino acid produced by esterase a c t i v i t y was determined as described by Reeves (J. Biol. Chem. 254: 8914, 1979) . For l e u and t r y p t , e f f l u x was compatible w i t h a i f f u s i o n model: strongly temperature dependent and unaltered by exogenous cations, ATP, o r amino acid. T-1/2 was comparable f o r leucine i n NL and CY (9.33 t .60[SEM] vs 9.18 + .92). NL T-1/2 was 13.7 + 1.03 f o r meth, 9.35 + 1.19 f o r phe, 22.6 + 3.97 f o r tryp.
I n contrast, T-1/2 f o r C was much longer (NL 92.0 * 15.9, CY 101 + 27.1). Apparent s i m i l a r i t i e s between NL and CY e f f l u x o f C a t these low rates require cautious interpretation. C e f f l u x from NL and CY increased upon exposure o f lysosomes t o 1mM cysteamine during e f f l u x ( 20.6 + 1.58 vs 26.1 + 2.74); i n contrast, 1mM reduced glutathione (GSH), a presumably l e s s penetrant t h i o l , d i d not cause a change i n C e f f l u x . E f f l u x o f other AA was unaltered by 1mM cysteamine o r GSH. W e conclude: there i s normal l e u e f f l u x and thus bo general defect i n lysosomal amino acid e f f l u x i n CY; the e f f l u x o f C i s exceptionally slow i n both NL and CY; cysteamine enhances C e f f l u x s e l e c t i v e l y i n isolated lysosomes, probably by penetration and subsequent reduct i o n o f C t o cysteine. cystine accumulation a f t e r 24 hrs incubation i n which 0.86 mg/106 c e l l s OVA was degraded. Addition o f OVA o r RBSA t o non-depleted c y s t i n o t i c fibroblasts produces cystine depletion (30% i n 4 hrs, 55% i n 24 hrs). W e conclude t h a t c y s t i n o t i c c e l l s accumulate cystine through the lysosomal r e t e n t i o n o f cystine, but not cysteine residues following t h e i r release from peptide chains during proteolysis. Supported by USPHS AM 25548.
CYSTINOTIC FIBROBLASTS ACCUMULATE CYSTINE FROM CYS-TINE BUT NOT CYSTEINE RESIDUES OF EXTRACELLULAR PRO-
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T u m a n and f MPS V I r e s u l t from d e f i c i e n t ASB a c t i v i t v ( s6% o f normal) and accumulation o f dermatan s u l f a t e (DS). NO& a1 human, normal f and f HPS V I hepatic ASB were p u r i f i e d (spec. act. 55, 106, 2.7 umol/h/mg prot., resp.) and molecular weights (MW) were determined by PAGE ( s 80,000, 160,000, 78,000, resp.) ' and Sephadex G-ZOO chromatography ( s 45,000, 110,000, 53,000, resp.). These data were consistent w i t h human ASB and rASB being monomers and the normal f ASB a dimer. When the rASB was incubated w i t h 1 m M DTT, the M W was 160,000 (PAGE) and 100,000 (Sephadex), suggesting t h a t DTT caused dimerization o f the rASB. The DTT-treated p u r i f i e d rASB was increased 5-fold and had markedly increased c r y o s t a b i l i t y .
Normal f and f MPS V I buffered whole bloods were incubated + 10 m M DTT, leukocytes isolated, ASA and ASB separated by DEAE-cellulose chromatography, and DS determined by cel loge1 electrophoresis. The WBC rASB a c t i v i t y was increased 6-fold w i t h DTT (spec. act. 0.025 + 0.164) and the DS was markedl y decreased (0.37-t < 0.02 ug/ ug prot. ); DTT had no e f f e c t on ASA, normal ASB, o r normal DS levels. These findings suggest t h a t the mutation i n f MPS V I may involve a cysteine residue which hinders dimerization and t h a t -SH reduction r e s u l t s i n d imerization with enhanced rASB a c t i v i t y . Thiol -induced subunit association provides a novel approach f o r enzyme manipulation therapy which can be tested i n vivo using the animal model.
ASSIGNMENT OF THE HUMAN GENE FOR LIVER TYPE PHOSPHO-FRUCTOKINASE ISOZYME TO CHROMOSOME 21 USING SOMATIC
769 CELL HYBRIDS. Shobhana Vora and Uta Fr anc, .
Columb i a Univ., C o l l . of Phys. and Surg., Dept. Ped., New York, NY and Yale Univ., Dept. Hum. Genet. and Ped., New Haven, CT.
Human phosphofructokinase (PFK, E.C.2.7.1.
11) i s under the c o n t r o l o f three s t r u c t u r a l l o c i which code f o r M (muscle), L ( l i v e r ) , and P ( p l a t e l e t ) type subunits. Human d i p l o i d f i b r ob l a s t s express a l l 3 genes; random tetramerization of r e s u l t i n g subunits produces various isozymes. We have analyzed 17 human x Chinese hamster hybrids segregating human chromoson~es f o r the expression o f human L subunits. Since electrophoresis does n o t d i s t i n g u i s h between the rodent o r human PFKs
,we employed an a n t ihuman L monoclonal antibody which does n o t react w i t h rodent PFK. The expression of human L subunits i n the hybrids was detected by the enzyme-immunoprecipitation technique using staphylococci bearing p r o t e i n A as an immunoadsorbent. 12 out of 1 7 hybrids expressed human L subunits and retained chromosome 21 whereas 5 d i d n o t express human PFKL and lacked chromosome 21. There was discordant segregation of a l l other human chromosomes and PFKL expression i n these hybrids. The mean RBC PFK o f 6 i n d i v i d u a l s w i t h trisomy 21 was found t o be elevated (147% o f normal). A spec i f i c increase i n L subunits i n trisomic RBC was evident chromatographically by an increase i n L-4 species and immunologically by decreased p r e c i p i t a t i o n w i t h anti-M monoclonal antibody. We Med., Div. o f Med. Genet., N.Y.C., N.I.H., Bethesda, MD. Osteogenesis Imperfecta Type I 1 (01, l e t h a l p e r i n a t a l ) has Human porphobilinogen (PBG) deaminase, the heme biosynthetic been presumed t o be i n h e r i t e d as an autosomal recessive t r a i t .
enzyme d e f i c i e n t i n acute i n t e r m i t t e n t porphyria, and ESA4 have I n an attempt t o t e s t t h i s hypothesis questionnaires were sent been mapped t o the long arm o f chromosome 11 by somatic c e l l hyt o a l l University Departments o f Medical Genetics i n Canada, b r i d i z a t i o n techniques. Man-mouse hybrids derived from the furequesting information about t h e i r ascertained cases o f 01 sion o f 2S mouse erythroleukemia (MEL) TK-c e l l s and human HGPRTType 11. Twenty-three kindreds were ascertained w i t h a t o i a l o f f i b r o b l a s t s have been used f o r studies on the induction and ex-23 sibs o f which 4 (17.4%) were affected. By the "singles pression o f human PBGD. PBGD was examined by i s o e l e c t r i c focusmethod of Davie (Ann. Hum. Gen. 42, 507, 1979 ) the estimated ing, immunop~ecipitation and rocket immunoelectrophoresis. Among segregation frequency was 0.17+0.024.
The sex r a t i o s o f a f f e c t e d 120 sub-clones generated from one primary clone (XX-8), a clone and normal i n d i v i d u a l s d i d not d i f f e r s i g n i f i c a n t l y from expectawas found which contained a single human chromosome consisting o f t i o n . There was no recognized parental consanguinity. The a 4/11 translocation (4q12::llqll). This clone was human PBGD segregation r a t i o i s s i g n i f i c a n t l y lower than 0.25 (P<0.01), and ESA4 p o s i t i v e and LDHA negative. From examination o f other suggesting the presence o f e i t h e r selective prenatal m o r t a l i t y primary and secondary clones, i t was possible t o r u l e out assigno r o f genetic heterogeneity. These findings support the contenment o f PBGD t o chromosome 4. Further regional l o c a l i z a t i o n was t i o n o f Young and Harper (Lancet I, 432, 1980) t h a t the empiric achieved by characterization o f 2s MEL (HGPRT-) x human f i b r o b l a s t recurrence r i s k for 01 Type I 1 i s less than 25%.
(GM 3552) hybrids containing an X/11 translocation (X;11) (q25-26; q23). One clone (MX/ll-2) contained only the i n t a c t X/11 translocated chromosome and was LDHA positive. I n a second clone (MX/ 11-3)(LDHA negative), the l l p portion o f the translocated chromosome was deleted and the remainder was translocated t o a mouse chromosome. Both clones were negative f o r human PBGD and ESA4. These r e s u l t s demonstrate t h a t human PBGD and ESA4 are encoded on human chromosome 11 i n the region l l q 2 3 + l l q t e r .
